Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?

Kidney international - 1 Apr 2006

Jacobsen P K, Tarnow L, Parving H-H

Abstract excerpt

One reason for the inadequacy of current renoprotective therapy and the persistent poor renal prognosis in diabetic nephropathy is the large interindividual variation in response to treatment. Genetic as well as non-genetic factors are known to influence treatment efficacy. This Commentary summar...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Asian People
Share to Diabetic Nephropathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Deletion

Share to Mutagenesis, Insertional

Share to Peptidyl-Dipeptidase A

Share to Prognosis

Share to Survival Analysis

Source

Identifiers

PMID: 16612410
DOI: 10.1038/sj.ki.5000283

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16612410-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?PMID 16612410Read ↗

ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information.Semantic proximity Read ↗

Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition.Semantic proximity Read ↗

ACE genotype and ACE inhibitor response in kidney disease: a perspective.Semantic proximity Read ↗

Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.Semantic proximity Read ↗

Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.Semantic proximity Read ↗

Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.Semantic proximity Read ↗

Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?Semantic proximity Read ↗

Interaction Between Genetic Polymorphisms in Renin-Angiotensin System (RAS) and Therapeutic Efficacy of RAS Blockade in IgA Nephropathy.Semantic proximity Read ↗

Pharmacogenomics of angiotensin converting enzyme inhibitors in renal disease--pathophysiological considerations.Semantic proximity Read ↗

Angiotensin converting enzyme gene polymorphisms and renal disease.Semantic proximity Read ↗

Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.Semantic proximity Read ↗

Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.